Archive_2020 Meeting | DOHaD Canada

2020 Meeting of the Canadian DOHaD Society

February 11 & 12, 2020
The Banff Centre– Banff, Alberta

4^th Annual Meeting to be held at the Banff Centre in Banff Alberta, 11 & 12 of February 2020.

DOHaD CANADA is pleased to announce its 4^th Annual Meeting to be held at the Banff Centre in Banff Alberta, on the 11^th & 12^th of February 2020.
This year, the DOHaD Canada scientific program will address new challenges for DOHaD in today’s environment. A detailed program will be released shortly. The meeting provides an important venue for information exchange and dissemination among Canadian DOHaD researchers, trainees, clinicians and policy leaders, and a forum for knowledge translation of the vastly relevant DOHaD research that is undertaken across Canada. This important event is expected to attract 120 participants and will showcase the work of trainees, new investigators and established DOHaD researchers. As we did last year, DOHaD Canada’s meeting has been scheduled immediately before the Canadian Perinatal Research Meeting (CNPRM) to ensure the best possible attendance and reach of our message.

The program will include Keynote addresses by Dr. Lucilla Poston, Head of the Department of Women and Children’s Health at King’s College London and Dr. Jed Friedman, Director of the Harold Hamm Diabetes Center at the University of Oklahoma Health Science Center.

Best regards,
Meeting Organizers:

Jennifer Thompson, PhD Assistant Professor Department of Physiology and Pharmacology Libin Cardiovascular Institute of Alberta University of Calgary

Meghan Riddell, PhD Assistant Professor Departments Obstetrics & Gynaecology and Physiology University of Alberta

Professor Lucilla Poston is the Tommy's Charity Professor of Maternal & Fetal Health and director of the Tommy’s Maternal and Fetal Research Unit based at St Thomas’ Hospital. She is the Research Lead for the Women's Health Clinical Academic Group (CAG) within King's Health Partners.

She leads a large multidisciplinary research team which investigates disorders of pregnancy including premature birth, pre-eclampsia and the complications arising from maternal obesity. Her own research group focuses on maternal nutrition, obesity and gestational diabetes, with a focus on the early life origins of health and disease.

Lucilla is an honorary Fellow of the Royal College of Obestricians and Gynaecologists (FRCOG) and was elected Fellow of the Academy of Medical Sciences in 2009. She was appointed as NIHR Senior Investigator, Emeritus status in 2017, having succeeded twice in open competition. In the same year, Lucilla was awarded a CBE for services to Women’s Health.

Dr. Jed Friedman is the director of the Harold Hamm Diabetes Center and vice provost for diabetes programs at the University of Oklahoma Health Sciences Center and Chickasaw Professor of Physiology at the University of Oklahoma College of Medicine. Dr. Friedman’s precious experience spans 18 years as the director of the Colorado NIH-Nutrition and Obesity Research Center (NORC) Molecular and Cellular Analytical core lab, with appointments in Pediatrics, Medicine, Biochemistry and Molecular Genetics. He has an established record of collaborative research in humans, primates, and mouse models of diabetes and obesity focused on pathways for developmental programming of metabolism from mothers to infants during the first 1000 days of life.

Dr. Friedman’s research spans the gamut from cells to humans and back again. His recent data demonstrate that mechanisms underlying development of obesity, diabetes, and neuro-cognitive behaviors across the lifespan may begin operating in fetal life and may permanently change the body’s structure, physiology, and metabolism that drive health risks in the next generation. Dr. Friedman uses a team science approach ranging from human epidemiology to metabolic studies in human tissues and cells and pre-clinical models of disease, to identify new targets and tools for diagnosis and treatment of mothers with obesity (1 in 3), diabetes (1 in 5), including nutritional countermeasures to halt obesity and diabetes in the next generation.

Meghan Riddell, PhD

Dr. Meghan Riddell is an Assistant Professor in the Departments of Obstetrics and Gynaecology and Physiology at the University of Alberta. Following her Ph.D. training in placental physiology at the University of Alberta (2013), she completed post-doctoral training at the Max Planck Institute for Heart and Lung Research (2014-2018) in developmental angiogenesis. She is a cell biologist focussed on developmental biology. Her main research focus is the molecular regulation of placental morphogenesis and the development of common pregnancy complications. She has particular interest in the cell biology of trophoblasts, a placental specific cell type, and angiogenesis. Her laboratory is also especially interested in how perturbation in development of the placenta leads to lifelong health consequences for both the mother and the fetus.

Dr. Jennifer Thompson is an Assistant Professor in the Department of Physiology & Pharmacology at the University of Calgary and Researcher at the Libin Cardiovascular Institute of Alberta. After obtaining her doctorate from the University of Western Ontario, she completed a postdoctoral fellowship at the Medical College of Georgia that was funded by an NIH K award. The overarching objective of her research is to identify the mechanisms linking environmental exposures to early-onset cardiovascular disease risk. She is a past recipient of a Young Investigator Cassady Presidential Award from the Perinatal Research Society and she currently holds a National New Investigator Award from the Heart and Stroke Foundation. Her research program is currently funded by the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Canada (HSFC) and the Canadian Foundation of Innovation (CFI).

2020 Meeting of the Canadian DOHaD SocietyFebruary 11 & 12, 2020
The Banff Centre– Banff, Alberta
4th Annual Meeting to be held at the Banff Centre in Banff Alberta, 11 & 12 of February 2020.
DOHaD CANADA is pleased to announce its 4th Annual Meeting to be held at the Banff Centre in Banff Alberta, on the 11th & 12th of February 2020.
This year, the DOHaD Canada scientific program will address new challenges for DOHaD in today’s environment. A detailed program will be released shortly. The meeting provides an important venue for information exchange and dissemination among Canadian DOHaD researchers, trainees, clinicians and policy leaders, and a forum for knowledge translation of the vastly relevant DOHaD research that is undertaken across Canada. This important event is expected to attract 120 participants and will showcase the work of trainees, new investigators and established DOHaD researchers. As we did last year, DOHaD Canada’s meeting has been scheduled immediately before the Canadian Perinatal Research Meeting (CNPRM) to ensure the best possible attendance and reach of our message.
The program will include Keynote addresses by Dr. Lucilla Poston, Head of the Department of Women and Children’s Health at King’s College London and Dr. Jed Friedman, Director of the Harold Hamm Diabetes Center at the University of Oklahoma Health Science Center.
Best regards,
Meeting Organizers:
Jennifer Thompson, PhD Assistant Professor Department of Physiology and Pharmacology Libin Cardiovascular Institute of Alberta University of Calgary
Meghan Riddell, PhD Assistant Professor Departments Obstetrics & Gynaecology and Physiology University of Alberta

▸ Programme

Please find the Preliminary Agenda attached (January 10, 2020 – subject to change).

▸ Registration

Registration Fee

Trainee:
member of DOHaD Canada and DOHaD International

$65

Faculty:
member of DOHaD Canada and DOHaD International

$140

Trainee:
not a member of DOHaD Canada and DOHaD International

$150

Faculty:
not a member of DOHaD Canada and DOHaD International

$250

▸ Abstract Submission

The Abstract Submission for Oral and Poster presentations is now closed (November 19, 2019).

▸ Keynote Speakers

Professor Lucilla Poston is the Tommy’s Charity Professor of Maternal & Fetal Health and director of the Tommy’s Maternal and Fetal Research Unit based at St Thomas’ Hospital. She is the Research Lead for the Women’s Health Clinical Academic Group (CAG) within King’s Health Partners.
She leads a large multidisciplinary research team which investigates disorders of pregnancy including premature birth, pre-eclampsia and the complications arising from maternal obesity. Her own research group focuses on maternal nutrition, obesity and gestational diabetes, with a focus on the early life origins of health and disease.
Lucilla is an honorary Fellow of the Royal College of Obestricians and Gynaecologists (FRCOG) and was elected Fellow of the Academy of Medical Sciences in 2009. She was appointed as NIHR Senior Investigator, Emeritus status in 2017, having succeeded twice in open competition. In the same year, Lucilla was awarded a CBE for services to Women’s Health.

Dr. Jed Friedman is the director of the Harold Hamm Diabetes Center and vice provost for diabetes programs at the University of Oklahoma Health Sciences Center and Chickasaw Professor of Physiology at the University of Oklahoma College of Medicine. Dr. Friedman’s precious experience spans 18 years as the director of the Colorado NIH-Nutrition and Obesity Research Center (NORC) Molecular and Cellular Analytical core lab, with appointments in Pediatrics, Medicine, Biochemistry and Molecular Genetics. He has an established record of collaborative research in humans, primates, and mouse models of diabetes and obesity focused on pathways for developmental programming of metabolism from mothers to infants during the first 1000 days of life.
Dr. Friedman’s research spans the gamut from cells to humans and back again. His recent data demonstrate that mechanisms underlying development of obesity, diabetes, and neuro-cognitive behaviors across the lifespan may begin operating in fetal life and may permanently change the body’s structure, physiology, and metabolism that drive health risks in the next generation. Dr. Friedman uses a team science approach ranging from human epidemiology to metabolic studies in human tissues and cells and pre-clinical models of disease, to identify new targets and tools for diagnosis and treatment of mothers with obesity (1 in 3), diabetes (1 in 5), including nutritional countermeasures to halt obesity and diabetes in the next generation.

▸ Local Organizing Committee

Meghan Riddell, PhD
Dr. Meghan Riddell is an Assistant Professor in the Departments of Obstetrics and Gynaecology and Physiology at the University of Alberta. Following her Ph.D. training in placental physiology at the University of Alberta (2013), she completed post-doctoral training at the Max Planck Institute for Heart and Lung Research (2014-2018) in developmental angiogenesis. She is a cell biologist focussed on developmental biology. Her main research focus is the molecular regulation of placental morphogenesis and the development of common pregnancy complications. She has particular interest in the cell biology of trophoblasts, a placental specific cell type, and angiogenesis. Her laboratory is also especially interested in how perturbation in development of the placenta leads to lifelong health consequences for both the mother and the fetus.

Dr. Jennifer Thompson is an Assistant Professor in the Department of Physiology & Pharmacology at the University of Calgary and Researcher at the Libin Cardiovascular Institute of Alberta. After obtaining her doctorate from the University of Western Ontario, she completed a postdoctoral fellowship at the Medical College of Georgia that was funded by an NIH K award. The overarching objective of her research is to identify the mechanisms linking environmental exposures to early-onset cardiovascular disease risk. She is a past recipient of a Young Investigator Cassady Presidential Award from the Perinatal Research Society and she currently holds a National New Investigator Award from the Heart and Stroke Foundation. Her research program is currently funded by the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Canada (HSFC) and the Canadian Foundation of Innovation (CFI).

▸ Accommodation

The DOHaD Canada meeting will take place at the Banff Centre for Arts and Creativity.

Banff Centre for Arts and Creativity
107 Tunnel Mountain Dr.
Banff, Alberta
T1L 1H5 Canada
(403) 762-6100

▸ Speakers – Faculty

▸ Speakers – Trainees

▸ Sponsors

Sponsors of the 2020 Scientific Meeting of the Canadian DOHaD Society:

Registration Fee
Trainee: member of DOHaD Canada and DOHaD International	$65
Faculty: member of DOHaD Canada and DOHaD International	$140
Trainee: not a member of DOHaD Canada and DOHaD International	$150
Faculty: not a member of DOHaD Canada and DOHaD International	$250